77 related articles for article (PubMed ID: 20530412)
21. The mRNA expression of inhibitors of DNA binding-1 and -2 is associated with advanced tumour stage and adverse clinical outcome in human breast cancer.
Wazir U; Jiang WG; Sharma AK; Newbold RF; Mokbel K
Anticancer Res; 2013 May; 33(5):2179-83. PubMed ID: 23645773
[TBL] [Abstract][Full Text] [Related]
22. Downregulation of DLEC1 in sinonasal inverted papilloma and squamous cell carcinoma.
Chang PH; Huang CC; Lee TJ; Lee YS; Tsai CN
J Otolaryngol Head Neck Surg; 2012 Apr; 41(2):94-101. PubMed ID: 22569009
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of downregulated expression of the candidate tumour suppressor gene SASH1 in colon cancer.
Rimkus C; Martini M; Friederichs J; Rosenberg R; Doll D; Siewert JR; Holzmann B; Janssen KP
Br J Cancer; 2006 Nov; 95(10):1419-23. PubMed ID: 17088907
[TBL] [Abstract][Full Text] [Related]
24. Candidate tumor-suppressor gene DLEC1 is frequently downregulated by promoter hypermethylation and histone hypoacetylation in human epithelial ovarian cancer.
Kwong J; Lee JY; Wong KK; Zhou X; Wong DT; Lo KW; Welch WR; Berkowitz RS; Mok SC
Neoplasia; 2006 Apr; 8(4):268-78. PubMed ID: 16756719
[TBL] [Abstract][Full Text] [Related]
25. Small suitability of the DLEC1, MLH1 and TUSC4 mRNA expression analysis as potential prognostic or differentiating markers for NSCLC patients in the Polish population.
Kordiak J; Czarnecka KH; Pastuszak-Lewandoska D; Antczak A; Migdalska-Sęk M; Nawrot E; Domańska-Senderowska D; Kiszałkiewicz J; Brzeziańska-Lasota E
J Genet; 2017 Jun; 96(2):227-234. PubMed ID: 28674222
[TBL] [Abstract][Full Text] [Related]
26. Suppression of ING1 expression in sporadic breast cancer.
Toyama T; Iwase H; Watson P; Muzik H; Saettler E; Magliocco A; DiFrancesco L; Forsyth P; Garkavtsev I; Kobayashi S; Riabowol K
Oncogene; 1999 Sep; 18(37):5187-93. PubMed ID: 10498868
[TBL] [Abstract][Full Text] [Related]
27. [mRNA expression of CK19 and CEA in peripheral blood of patients with breast cancer detected by real-time quantitative PCR].
Zheng HY; Chen Q; Ye YB; Huang WW
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(32):2267-70. PubMed ID: 19087676
[TBL] [Abstract][Full Text] [Related]
28. Aberrant expression of 5-lipoxygenase-activating protein (5-LOXAP) has prognostic and survival significance in patients with breast cancer.
Jiang WG; Douglas-Jones AG; Mansel RE
Prostaglandins Leukot Essent Fatty Acids; 2006 Feb; 74(2):125-34. PubMed ID: 16364620
[TBL] [Abstract][Full Text] [Related]
29. Semaphorin-plexin signalling genes associated with human breast tumourigenesis.
Gabrovska PN; Smith RA; Tiang T; Weinstein SR; Haupt LM; Griffiths LR
Gene; 2011 Dec; 489(2):63-9. PubMed ID: 21925246
[TBL] [Abstract][Full Text] [Related]
30. WWOX--the FRA16D cancer gene: expression correlation with breast cancer progression and prognosis.
Płuciennik E; Kusińska R; Potemski P; Kubiak R; Kordek R; Bednarek AK
Eur J Surg Oncol; 2006 Mar; 32(2):153-7. PubMed ID: 16360296
[TBL] [Abstract][Full Text] [Related]
31. The tumor suppressor gene DLEC1 is frequently silenced by DNA methylation in hepatocellular carcinoma and induces G1 arrest in cell cycle.
Qiu GH; Salto-Tellez M; Ross JA; Yeo W; Cui Y; Wheelhouse N; Chen GG; Harrison D; Lai P; Tao Q; Hooi SC
J Hepatol; 2008 Mar; 48(3):433-41. PubMed ID: 18191269
[TBL] [Abstract][Full Text] [Related]
32. WNT5A expression in human breast cancer.
Leris AC; Roberts TR; Jiang WG; Newbold RF; Mokbel K
Anticancer Res; 2005; 25(2A):731-4. PubMed ID: 15868903
[TBL] [Abstract][Full Text] [Related]
33. Aberrant expression of tumor suppressors CADM1 and 4.1B in invasive lesions of primary breast cancer.
Takahashi Y; Iwai M; Kawai T; Arakawa A; Ito T; Sakurai-Yageta M; Ito A; Goto A; Saito M; Kasumi F; Murakami Y
Breast Cancer; 2012 Jul; 19(3):242-52. PubMed ID: 21526423
[TBL] [Abstract][Full Text] [Related]
34. 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells.
Zheng J; Kulp SK; Zhang Y; Sugimoto Y; Dayton MA; Govindan MV; Brueggemeier RW; Lin YC
Anticancer Res; 2000; 20(1A):11-9. PubMed ID: 10769629
[TBL] [Abstract][Full Text] [Related]
35. Reduced vascular endothelial growth inhibitor (VEGI) expression is associated with poor prognosis in breast cancer patients.
Parr C; Gan CH; Watkins G; Jiang WG
Angiogenesis; 2006; 9(2):73-81. PubMed ID: 16758268
[TBL] [Abstract][Full Text] [Related]
36. Evidence for a tumour suppressor function of SETD2 in human breast cancer: a new hypothesis.
Newbold RF; Mokbel K
Anticancer Res; 2010 Sep; 30(9):3309-11. PubMed ID: 20944102
[TBL] [Abstract][Full Text] [Related]
37. Methylation of DLEC1 promoter is a predictor for recurrence in Chinese patients with gastric cancer.
Ye X; Feng G; Jiao N; Pu C; Zhao G; Sun G
Dis Markers; 2014; 2014():804023. PubMed ID: 25574068
[TBL] [Abstract][Full Text] [Related]
38. RBM5/H37 tumor suppressor, located at the lung cancer hot spot 3p21.3, alters expression of genes involved in metastasis.
Oh JJ; Taschereau EO; Koegel AK; Ginther CL; Rotow JK; Isfahani KZ; Slamon DJ
Lung Cancer; 2010 Dec; 70(3):253-62. PubMed ID: 20338664
[TBL] [Abstract][Full Text] [Related]
39. Insulin-like growth factor 1 (IGF-1) and its receptor mRNA levels in breast cancer and adjacent non-neoplastic tissue.
Chong YM; Williams SL; Elkak A; Sharma AK; Mokbel K
Anticancer Res; 2006; 26(1A):167-73. PubMed ID: 16475694
[TBL] [Abstract][Full Text] [Related]
40. [Expression of estrogen sulfotransferase (EST) gene and bridging integrator protein-1 (BIN1) gene and their significance in breast tissues].
Deng WH; Wu YY; Yang L; Tang WQ; Wang S
Ai Zheng; 2004 Nov; 23(11):1302-5. PubMed ID: 15522178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
